Literature DB >> 20335540

Is risk of Alzheimer disease a reason to use dietary supplements?

Johanna Dwyer, Maria DeTolve Donoghue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20335540      PMCID： PMC2854895          DOI： 10.3945/ajcn.2010.29498

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN： 0002-9165            Impact factor:   7.045


× No keyword cloud information.
  16 in total

1.  The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

Authors:  Steven T DeKosky; Annette Fitzpatrick; Diane G Ives; Judith Saxton; Jeff Williamson; Oscar L Lopez; Gregory Burke; Linda Fried; Lewis H Kuller; John Robbins; Russell Tracy; Nancy Woolard; Leslie Dunn; Richard Kronmal; Richard Nahin; Curt Furberg
Journal:  Contemp Clin Trials       Date:  2006-04-19       Impact factor: 2.226

Review 2.  Omega 3 fatty acid for the prevention of dementia.

Authors:  W S Lim; J K Gammack; J Van Niekerk; A D Dangour
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 3.  Statins for the prevention of dementia.

Authors:  Bernadette McGuinness; David Craig; Roger Bullock; Peter Passmore
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 4.  The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.

Authors:  S G Post; P J Whitehouse; R H Binstock; T D Bird; S K Eckert; L A Farrer; L M Fleck; A D Gaines; E T Juengst; H Karlinsky; S Miles; T H Murray; K A Quaid; N R Relkin; A D Roses; P H St George-Hyslop; G A Sachs; B Steinbock; E F Truschke; A B Zinn
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

5.  Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial.

Authors:  Simone J Eussen; Lisette C de Groot; Liesbeth W Joosten; Rubia J Bloo; Robert Clarke; Per M Ueland; Jörn Schneede; Henk J Blom; Willibrord H Hoefnagels; Wija A van Staveren
Journal:  Am J Clin Nutr       Date:  2006-08       Impact factor: 7.045

6.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

Authors:  Rita Peila; Beatriz L Rodriguez; Lenore J Launer
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

7.  Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.

Authors:  Jacqueline A Vernarelli; J Scott Roberts; Susan Hiraki; Clara A Chen; L Adrienne Cupples; Robert C Green
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

8.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study.

Authors:  A Hofman; A Ott; M M Breteler; M L Bots; A J Slooter; F van Harskamp; C N van Duijn; C Van Broeckhoven; D E Grobbee
Journal:  Lancet       Date:  1997-01-18       Impact factor: 79.321

9.  High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Authors:  Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron F Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

10.  Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Authors:  Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.